Search

Background Currently, the treatment of refractory epilepsy (RE) in children is still a difficult point in epilepsy treatment. In China, pirenzapine (PER) is still a new drug for treating RE in children, and there is currently a lack of recommendations for adding PER to the treatment of RE in children. And in Chinese reports, the sample size of RE patients treated with PER is relatively small. Therefore, the efficacy of PER for pediatric RE, especially for young children with RE, still needs to be further studied with a large sample size. Objective To explore the efficacy, possible indications, adverse reactions, and tolerability of PER addition therapy for RE in children. Methods A self-control and retrospective analysis was conducted on children with RE aged 0-18 who were treated at the Women and Children's Hospital, Qingdao University from January 2022 to January 2023. The frequency of seizures at different observation points before and after the addition of PER treatment was compared, and the effective rate of PER was evaluated. Adverse drug reactions and drug retention rates were recorded, and the clinical characteristics of the effective and ineffective groups of PER were analyzed. Results A total of 192 study subjects were included. After adding PER treatment, the effective rates at 12, 24, and 36 weeks were 56.3% (108/192), 62.1% (113/182), and 69.7% (122/175), respectively, and the seizure free rates were 19.3% (37/192), 21.4% (39/182), and 24.6% (43/175). The incidence of adverse reactions was 16.1% (31/192), mainly including dizziness, irritability, weakness, and drowsiness. The last follow-up drug retention rate was 91.1% (175/192). There was a statistically significant difference in the onset age, duration of anti-epileptic treatment, type of origin, seizure form, frequency of seizures before the addition of PER, number of combined anti-epileptic drugs (ASMs), and ketogenic diet/surgical treatment between patients with RE who received continuous medication for 12 weeks (P

In recent years, heavy ion accelerator technology has been rapidly developing worldwide and widely applied in the fields of space radiation simulation and particle therapy. Usually, a very high uniformity in the irradiation area is required for the extracted ion beams, which is crucial because it directly affects the experimental precision and therapeutic effect. Specifically, ultra-large-area and high-uniformity scanning are crucial requirements for spacecraft radiation effects assessment and serve as core specification for beamline terminal design. In the 300 MeV proton and heavy ion accelerator complex at the Space Environment Simulation and Research Infrastructure (SESRI), proton and heavy ion beams will be accelerated and ultimately delivered to three irradiation terminals. In order to achieve the required large irradiation area of 320 mm×320 mm, horizontal and vertical scanning magnets are used in the extraction beam line. However, considering the various requirements for beam species and energies, the tracking accuracy of power supplies (PSs), the eddy current effect of scanning magnets, and the fluctuation of ion bunch structure will reduce the irradiation uniformity. To mitigate these effects, a beam uniformity optimization method based on the measured beam distribution was proposed and applied in the accelerator complex at SESRI. In the experiment, the uniformity is successfully optimized from 75% to over 90% after five iterations of adjustment to the PS waveforms. In this paper, the method and experimental results were introduced.

In a cold and high humidity environment, ice and frost are easy to condense on the surfaces of aircraft, railway transportation, wind turbine blades, transmission lines and other equipment, thus reducing work efficiency, affecting the proper use of equipment, and causing huge security risks. Therefore, how to effectively delay the formation of frost on the surfaces of solid materials and promote the removal of ice has become a research hot topic in the field of high-performance materials. Conventionalde-icing methods including mechanical, chemical, and thermal de-icing have the problems of high energy consumption, excessive de-icing waste liquidlow de-icing efficiency, and easy to damage the surface of equipment, which are contrary to the sustainable development concept of “green, environmental protection, high efficiency and energy saving”. Inspired by natural biology, researchers have developed some new passive superhydrophobic anti-icing technologies, which have the advantages of low cost, low energy consumption and excellent anti-ice performance, and perform high application prospect. In this paper, for the new superhydrophobic anti-icing materials, the theoretical progress of superhydrophobic wetting of solid surfaces and the icingand anti-icing mechanism of solid surfaces were reviewed. The top-down preparation methods (laser etching, chemical etching, template method, etc.) and bottom-up preparation methods (coating technology, magnetron sputtering technology, sol-gel technology and electrodeposition technology, etc.) of superhydrophobic anti-icing surface were summarized. Finally, the limitations of superhydrophobic anti-icing materials were discussed, and their application prospect and development trend were forecasted.

Background and purpose: Invasive breast carcinoma is the most prevalent malignancy in women worldwide and has a poor prognosis. Tumor xenobiotics change the tumor microenvironment and participate in the regulation of tumor occurrence, development and metastasis, which provide new ideas for the diagnosis and treatment of tumors. DZNep can target and regulate the degradation of H3K27me3 histone methyltransferase and specifically induce tumor cell apoptosis, thereby inhibiting cell proliferation and migration in a variety of tumors. In this study, we investigated the effect of DZNep on invasive breast carcinoma exosomes and observed its effect on epithelial-mesenchymal transition (EMT) of breast cancer cells by regulating intercellular junctions. Methods: EZH2 expression in invasive breast carcinoma was analyzed using the The Cancer Genome Atlas (TCGA) database and the online analysis software GEPIA2, and the Tumor Immunity Estimation Resources (TIMER) was used to analyze the relationship between EZH2 and the expressions of tumor microenvironment cytokines and EMT-related proteins. Intervention of invasive breast carcinoma MDA-MB-231 with DZNep and extraction of exosomes using differential ultracentrifugation were performed. Exosome membrane-bound protein expression was identified by detecting the expressions of CD9, CD63 and TSG101 using Western blot. The Brownian motion of exosomes was tracked and analyzed by nanoparticle tracking analysis (NTA) technique, and the hydrodynamic diameter and concentration of exosome particles were calculated in combination with the Stokes-Einstein equation. Transmission electron microscopy analysis of the size and shape of exosomes was carried out. The above methods were used to explore the changes of exogenous exosomes in breast cancer induced by DZNep. In addition, Western blot was used to detect the expressions of EZH2, intercellular junction proteins such as occludin, zonula occludens-1 (ZO-1), laminin, aquaporin 4 (AQP4), connexin 43, claudin5 and collagen Ⅵ, and EMT-related proteins such as E-cadherin and vimentin, respectively, to analyze the regulatory mechanism of DZNep on the tumor microenvironment.Results: EZH2 expression was higher in cancer tissues than in normal tissues. High EZH2 expression was positively correlated with the upregulation of both invasive breast carcinoma immune cells and stromal cells in Luminal A, positively correlated with E-cadherin, N-cadherin and vimentin expressions in invasive breast carcinoma, positively correlated with E-cadherin expression and negatively correlated with N-cadherin expression in BRCA-Luminal B, and positively correlated with N-cadherin and vimentin expressions in BRCA-Luminal A (P

Circularly polarized multi‐resonance thermally activated delayed fluorescence (CP‐MR‐TADF) materials, capable of achieving circularly polarized luminescence (CPL), play a crucial role in the field of 3D display. In this study, two pairs of axial chiral MR‐TADF enantiomers, (R/S)‐S‐AX‐BN and (R/S)‐SO2‐AX‐BN, are synthesized by fusing biphenyl skeletons containing sulfur/sulfone with classic B/N‐embedded polycyclic aromatic hydrocarbons. These compounds exhibit good photophysical properties with intense CPL. (R/S)‐S‐AX‐BN and (R/S)‐SO2‐AX‐BN display green photoluminescence, with peaks at 489 and 495 nm, full‐width at half‐maximum (FWHM) values of 21 and 20 nm in toluene, and dissymmetry factors (|gPL|) of 3.5 × 10−3 and 2.3 × 10−3 in doped films, respectively. Additionally, circularly polarized organic light‐emitting diodes (CP‐OLEDs) fabricated from (R/S)‐S‐AX‐BN and (R/S)‐SO2‐AX‐BN exhibit narrow electroluminescence (EL) spectra with FWHMs of 22 and 21 nm. These CP‐OLEDs achieve high maximum external quantum efficiencies of 33.5% and 31.5%, with relatively low efficiency roll‐offs. Furthermore, they exhibit high |gEL| factors of 3.3 × 10−3 and 2.2 × 10−3, respectively, representing the highest values among axial chiral analogs. This work introduces a novel approach for designing axial chiral CP‐MR‐TADF molecules and provides a reference for fabricating narrowband CP‐OLEDs with high efficiency and intense CPL. [ABSTRACT FROM AUTHOR]

C66H34N4O12F12Er2, triclinic, P1̄ (no. 2), a = 11.8934(5) Å, b = 12.0041(4) Å, c = 12.4578(5) Å, α = 68.718(4)°, β = 64.205(4)°, γ = 87.053(3)°, V = 1480.09(12) Å3, Z = 1, Rgt(F) = 0.0326, wRref(F2) = 0.0626, T = 293(2) K.

Inflammatory cytokines participate in the pathology of epilepsy and the development of drug resistance. In this study, we combined a cytokine array and enzyme-linked immunosorbent assay to identify new cytokines in the plasma from children on early stage of the onset of epilepsy (EOE) and children with drug-resistant epilepsy (DRE). Compared with healthy controls, a broad up-regulation of cytokines was observed in patients with EOE, and many of the cytokines were not previously reported. In patients with DRE, most of these up-regulated cytokines maintained at relatively low levels close to those in controls; only a few of them, including CCL5, Serpin E1, and IGFBP2, remained at high levels. The dramatic difference in cytokine profile could be a strong clue for the incidence of DRE, and DRE-associated cytokines appeared to have the potential to be new biomarkers for epilepsy prognosis and therapeutic targets. [ABSTRACT FROM AUTHOR]